Gene · 8013
Papers2,089
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,089
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncocytoid Salivary Tumors: Differential Diagnosis and Utility of Newly Described Immunohistochemistry. | Head Neck Pathol | 2024 | 38502259 | PubTator, text mining | PubMed |
| Orphan Nuclear Receptor Family 4A (NR4A) Members NR4A2 and NR4A3 Selectively Modulate Elements of the Monocyte Response to Buffered Hypercapnia. | Int J Mol Sci | 2024 | 38474099 | PubTator, text mining | PubMed |
| CHRNA6 RNA In Situ Hybridization Is a Useful Tool for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma. | Mod Pathol | 2024 | 38447752 | PubTator, text mining | PubMed |
| Structural Perspective of NR4A Nuclear Receptor Family and Their Potential Endogenous Ligands. | Biol Pharm Bull | 2024 | 38432913 | PubTator, text mining | PubMed |
| Lysyl oxidase expression in smooth muscle cells determines the level of intima calcification in hypercholesterolemia-induced atherosclerosis. | Clin Investig Arterioscler | 2024 | 38402026 | PubTator, text mining | PubMed |
| Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms. | Int J Mol Sci | 2024 | 38339014 | PubTator, text mining | PubMed |
| An Endosomal Acid-Regulatory Feedback System Rewires Cytosolic cAMP Metabolism and Drives Tumor Progression. | Mol Cancer Res | 2024 | 38319300 | PubTator, text mining | PubMed |
| Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma. | Hepatol Commun | 2024 | 38285876 | PubTator, text mining | PubMed |
| Using deep learning to quantify neuronal activation from single-cell and spatial transcriptomic data. | Nat Commun | 2024 | 38278804 | PubTator, text mining | PubMed |
| Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases. | Medicina (Kaunas) | 2024 | 38276058 | PubTator, text mining | PubMed |
| circGRHPR inhibits aberrant epithelial-mesenchymal transformation progression of lung epithelial cells associated with idiopathic pulmonary fibrosis. | Cell Biol Toxicol | 2024 | 38267743 | PubTator, text mining | PubMed |
| Potential Roles of Nr4a3-Mediated Inflammation in Immunological and Neurological Diseases. | Mol Neurobiol | 2024 | 38261254 | PubTator, text mining | PubMed |
| Identifying novel gene dysregulation associated with opioid overdose death: A meta-analysis of differential gene expression in human prefrontal cortex. | medRxiv | 2024 | 38260365 | PubTator, text mining | PubMed |
| Role of Epigenetics for the Efficacy of Cisplatin. | Int J Mol Sci | 2024 | 38256203 | PubTator, text mining | PubMed |
| Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma. | Diagn Pathol | 2024 | 38254207 | PubTator, text mining | PubMed |
| Identification and validation of prognostic genes and immune landscape signatures based on a fatty acid oxidation‑related risk score model in glioma. | Oncol Lett | 2024 | 38249808 | PubTator, text mining | PubMed |
| The effector program of human CD8 T cells supports tissue remodeling. | J Exp Med | 2024 | 38226976 | PubTator, text mining | PubMed |
| CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer. | Immunotargets Ther | 2024 | 38223406 | PubTator, text mining | PubMed |
| Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1. | Nat Commun | 2024 | 38167417 | PubTator, text mining | PubMed |
| Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators. | Histol Histopathol | 2024 | 38116863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8013/papers?page=8